Milestone Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Milestone Pharmaceuticals's balance sheet done over the years? Its assets were worth $75,226,000 last year, which is more than in the previous period. 78% of Milestone Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $58,455,000, which means an increase by 619% compared compared to last year.

Debt to Assets

Milestone Pharmaceuticals Inc. (NASDAQ:MIST): Debt to assets
2017 27590000 60.70M 220.04%
2018 88081000 143.29M 162.68%
2019 123428000 8.51M 6.9%
2020 149974000 6.85M 4.57%
2021 119849000 7.24M 6.05%
2022 74483000 8.13M 10.92%
2023 75226000 58.45M 77.71%

MIST Balance Sheet (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
13.76M7.63M114.14M72.31M119.81M85.94M10.88M
Short term investments
52.24M56.94M070M029K16.03M
Net receivables
3.85M1.21M483K948K836K677K543K
Inventory
0-331K-356K-725K-578K00
Other current assets
3.17M6.33M4.65M6.15M2.42M1.39M100K
Total current assets
73.03M71.80M118.92M148.68M122.49M88.05M27.55M
Non-current assets:
Property, Plant and Equipment
2.19M2.68M926K1.28M929K30K35K
Goodwill
0000000
Intangible assets
0000000
Long term investments
0000000
Other non-current assets
0-2.68M-926K-1.28M-929K00
Total non-current assets
2.19M2.68M926K1.28M929K30K35K
Total assets
75.22M74.48M119.84M149.97M123.42M88.08M27.59M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000000
Short term debt
1.09M495K224K245K330K00
Total current liabilities
7.22M6.13M6.77M6.15M8.32M4.53M1.60M
Non-current liabilities:
Long term debt
51.22M1.99M474K696K184K00
Deferred tax
0000000
Other non-current liabilities
00000138.75M59.10M
Total non-current liabilities
51.22M1.99M474K696K184K138.75M59.10M
Total liabilities
58.45M8.13M7.24M6.85M8.51M143.29M60.70M
Data sourceData sourceData sourceData sourceData source